We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Australia's Free Trade Agreement (FTA) with the US, implemented on
Jan. 1, has further tightened patent legislation, and strengthened data and
marketing exclusivity provisions.
Drugmaker IPCA Laboratories has entered into a an equal joint venture with China's
Chongqing Holley Holding Company to market Artemisinin-based drugs globally,
the Bombay Stock Exchange said on Friday.
Neose Technologies entered into a research, license and option agreement Thursday
with BioGenerix AG of Germany that could earn Neose up to $61.5 million in research
milestone payments.
Shire Pharmaceuticals Group Plc, the UK's third-biggest drugmaker, said first-quarter
profit fell 73 percent after it spent more on research and marketing.
Europe is slipping ever further
behind the U.S. in innovation in the drug industry and needs to revamp its research
and healthcare systems to reverse the trend, according to a report to be released
by the European Commission next month.
A two-year investigation into the whereabouts of international aid
donated to Kenya's National AIDS Control Council (NACC) has indicated that officials
misallocated funds totalling KES4.3bn (US$56.17mn).